Skip to content

Clinical trials

Disease Progression trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Progression Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20071
20111
20121
20141
20171
20191
20212
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Unknown status2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)2
AVEO Pharmaceuticals, Inc.1
Agouron Pharmaceuticals1
Biogen1
Centre hospitalier de l'Université de Montréal (CHUM)1
Eli Lilly and Company1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
McGill University1
Ontario Clinical Oncology Group (OCOG)1
Opexa Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease Progression13
HIV Infections3
Multiple Sclerosis3
Amyotrophic Lateral Sclerosis1
Autoimmune Diseases of the Nervous System1
Brain Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Connective Tissue Diseases1
Diabetes Mellitus1

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.